Abstract:BackgroundThe cell-surface protein CD38 mediates airway smooth muscle (ASM) contractility by generating cyclic ADP-ribose, a calcium-mobilizing molecule. In human ASM cells, TNF-α augments CD38 expression transcriptionally by NF-κB and AP-1 activation and involving MAPK and PI3K signaling. CD38−/− mice develop attenuated airway hyperresponsiveness following allergen or cytokine challenge. The post-transcriptional regulation of CD38 expression in ASM is relatively less understood. In ASM, microRNAs (miRNAs) regulate inflammation, contractility, and hyperproliferation. The 3’ Untranslated Region (3’UTR) of CD38 has multiple miRNA binding sites, including a site for miR-708. MiR-708 is known to regulate PI3K/AKT signaling and hyperproliferation of other cell types. We investigated miR-708 expression, its regulation of CD38 expression and the underlying mechanisms involved in such regulation in human ASM cells.MethodsGrowth-arrested human ASM cells from asthmatic and non-asthmatic donors were used. MiRNA and mRNA expression were measured by quantitative real-time PCR. CD38 enzymatic activity was measured by a reverse cyclase assay. Total and phosphorylated MAPKs and PI3K/AKT as well as enzymes that regulate their activation were determined by Western blot analysis of cell lysates following miRNA transfection and TNF-α stimulation. Dual luciferase reporter assays were performed to determine whether miR-708 binds directly to CD38 3’UTR to alter gene expression.ResultsUsing target prediction algorithms, we identified several miRNAs with potential CD38 3’UTR target sites and determined miR-708 as a potential candidate for regulation of CD38 expression based on its expression and regulation by TNF-α. TNF-α caused a decrease in miR-708 expression in cells from non-asthmatics while it increased its expression in cells from asthmatics. Dual luciferase reporter assays in NIH-3 T3 cells revealed regulation of expression by direct binding of miR-708 to CD38 3’UTR. In ASM cells, miR-708 decreased CD38 expression by decreasing phosphorylation of JNK MAPK and AKT. These effects were associated with increased expression of MKP-1, a MAP kinase phosphatase and PTEN, a phosphatase that terminates PI3 kinase signaling.ConclusionsIn human ASM cells, TNF-α-induced CD38 expression is regulated by miR-708 directly binding to 3’UTR and indirectly by regulating JNK MAPK and PI3K/AKT signaling and has the potential to control airway inflammation, ASM contractility and proliferation.

MicroRNA Mediated Chemokine Responses in Human Airway Smooth Muscle Cells

MicroRNA in Children with Asthma: Findings from Bronchoalveolar Lavage Fluid

Pulmonary Microrna Profiles Identify Involvement of Creb1 and Sec14l3 in Bronchial Epithelial Changes in Allergic Asthma

MicroRNA-200a Affects the Proliferation of Airway Smooth Muscle Cells and Airway Remodeling by Targeting FOXC1 Via the PI3K/AKT Signaling Pathway in Ovalbumin-Induced Asthmatic Mice.

MicroRNA-708 regulates CD38 expression through signaling pathways JNK MAP kinase and PTEN/AKT in human airway smooth muscle cells

Effect of miR-506-3p on Proliferation and Apoptosis of Airway Smooth Muscle Cells in Asthmatic Mice by Regulating CCL2 Gene Expression and Mediating TLR4/NF-κB Signaling Pathway Activation

Micrornas And Asthma Regulation

MicroRNA‐638 Inhibits Human Airway Smooth Muscle Cell Proliferation and Migration Through Targeting Cyclin D1 and NOR1

Mir-511-3p Limits Allergic Inflammation Through M2 Macrophage Polarization And Modulating Ccl2 Expression

Microrna-638 Inhibits Human Airway Smooth Muscle Cell Proliferation And Migration Through Targeting Cyclin D1 And Nor1

Effects of Mirna-145 on Airway Smooth Muscle Cells Function

MiR-143-3p Controls TGF-β1-induced Cell Proliferation and Extracellular Matrix Production in Airway Smooth Muscle Via Negative Regulation of the Nuclear Factor of Activated T Cells 1.

MicroRNA-485-3p promotes the inflammatory response and extracellular matrix deposition by activating Wnt/?-catenin signaling in human airway smooth muscle cells

Molecular Background of miRNA Role in Asthma and COPD: An Updated Insight

miRNA-based identification of SEC14L3 deregulation in murine experimental asthma

MiR-216a Inhibits Proliferation and Promotes Apoptosis of Human Airway Smooth Muscle Cells by Targeting JAK2

MiR-200a and miR-200b restrain inflammation by targeting ORMDL3 to regulate the ERK/MMP-9 pathway in asthma

The MicroRNAs Involved in Asthma Following Mesenchymal Stem Cell Treatment.

The miR-9-5p/KLF5/IL-1β Axis Regulates Airway Smooth Muscle Cell Proliferation and Apoptosis to Aggravate Airway Remodeling and Inflammation in Asthma

Down-regulation of key regulatory factors in sphingosine-1-phosphate (S1P) pathway in human lung fibroblasts transfected with selected microRNAs

MicroRNA-155 differentially regulates IL-13Rα1 and IL-13Rα2 expression and signaling that drives abnormal epithelial cells functions in severe asthma